Juvenescence’s Latest Venture, MDI Therapeutics, Inc., Targeting Fibrotic Disease
Juvenescence Ltd., a biopharmaceutical company, is pleased to announce its new equity investment in MDI Therapeutics, Inc. a company developing novel serpin-based therapies for the treatment of fibrosis and fibroproliferative...